IRADIMED (IRMD) CEO-linked trust sells 7,500 shares under 10b5-1 plan

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

IRADIMED CORP director and CEO Roger E. Susi reported indirect open‑market sales of a total of 7,500 shares of common stock by the Phillip Susi 2008 Dynasty Trust on May 4–5, 2026, at prices including $87.31 and $83.78 per share.

The transactions were carried out under a Rule 10b5-1 trading plan adopted on November 5, 2025, indicating they were pre‑scheduled. The filing also reflects indirect holdings through additional family trusts, and Susi disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest.

Insider Trade Summary 10b5-1

Net Seller: 7,500 shares ($642,862)

Net Sell 9 txns

Insider Susi Roger E.

Role CEO, President, Chairman

Sold 7,500 shs ($643K)

Type	Security	Shares	Price	Value
Sale	Common Stock	600	$83.78	$50K
Sale	Common Stock	1,322	$85.56	$113K
Sale	Common Stock	1,650	$86.43	$143K
Sale	Common Stock	178	$87.31	$16K
Sale	Common Stock	2,447	$85.32	$209K
Sale	Common Stock	1,103	$86.26	$95K
Sale	Common Stock	200	$87.05	$17K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 2,190,650 shares (Indirect, By Phillip Susi 2008 Dynasty Trust)

Footnotes (1)

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. This transaction was executed in multiple trades at prices ranging from $84.86 to $85.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $85.91 to $86.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $83.42 to $84.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $84.90 to $85.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $85.93 to $86.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $86.94 to $87.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.

Key Figures

Shares sold: 7,500 shares Sample sale price: $87.31 per share Sample sale price: $83.78 per share +3 more

6 metrics

Shares sold 7,500 shares Total open-market sales reported on May 4–5, 2026

Sample sale price $87.31 per share Common stock sale price on May 5, 2026

Sample sale price $83.78 per share Common stock sale price on May 5, 2026

Rule 10b5-1 plan adoption November 5, 2025 Date the pre-set trading plan was adopted

Single transaction size 2,447 shares Largest individual reported sale of common stock

Additional transaction size 1,650 shares Another reported block of common stock sold

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, beneficial ownership, Section 16, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"The price reported above reflects the weighted average sale price."

beneficial ownership financial

"The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Section 16 regulatory

"shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16"

Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 Insider Transactions: What Each Field Means →

05/06/2026 - 01:51 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Susi Roger E.

(Last)

(First)

(Middle)

C/O IRADIMED CORPORATION

12705 INGENUITY DRIVE

(Street)

ORLANDO

FLORIDA

32826

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IRADIMED CORP [ IRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, President, Chairman

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/04/2026		S⁽¹⁾		2,447	D	$85.32⁽²⁾	2,192,553	I	By Phillip Susi 2008 Dynasty Trust
Common Stock	05/04/2026		S⁽¹⁾		1,103	D	$86.26⁽³⁾	2,191,450	I	By Phillip Susi 2008 Dynasty Trust
Common Stock	05/04/2026		S⁽¹⁾		200	D	$87.05	2,191,250	I	By Phillip Susi 2008 Dynasty Trust
Common Stock	05/05/2026		S⁽¹⁾		600	D	$83.78⁽⁴⁾	2,190,650	I	By Phillip Susi 2008 Dynasty Trust
Common Stock	05/05/2026		S⁽¹⁾		1,322	D	$85.56⁽⁵⁾	2,189,328	I	By Phillip Susi 2008 Dynasty Trust
Common Stock	05/05/2026		S⁽¹⁾		1,650	D	$86.43⁽⁶⁾	2,187,678	I	By Phillip Susi 2008 Dynasty Trust
Common Stock	05/05/2026		S⁽¹⁾		178	D	$87.31⁽⁷⁾	2,187,500	I	By Phillip Susi 2008 Dynasty Trust
Common Stock								162,950	I	By Roger E. Susi Revocable Trust
Common Stock								2,062,500⁽⁸⁾	I	By Matthew Susi 2008 Dynasty Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.

2. This transaction was executed in multiple trades at prices ranging from $84.86 to $85.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. This transaction was executed in multiple trades at prices ranging from $85.91 to $86.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

4. This transaction was executed in multiple trades at prices ranging from $83.42 to $84.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

5. This transaction was executed in multiple trades at prices ranging from $84.90 to $85.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

6. This transaction was executed in multiple trades at prices ranging from $85.93 to $86.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

7. This transaction was executed in multiple trades at prices ranging from $86.94 to $87.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

8. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.

Remarks:

	/s/ Roger E. Susi	05/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did IRMD’s Roger E. Susi report on this Form 4?

Roger E. Susi reported indirect sales totaling 7,500 IRMD shares. The shares of common stock were sold in multiple open‑market transactions by the Phillip Susi 2008 Dynasty Trust on May 4–5, 2026, at prices in the mid‑$80s per share.

At what prices were the IRMD shares sold in Roger E. Susi’s Form 4?

The reported IRMD share sales occurred around the mid‑$80s per share. Individual transactions include prices such as $87.31, $86.43, $85.56, and $83.78, reflecting multiple trades executed over May 4–5, 2026.

Were the IRMD insider sales by Roger E. Susi pre-planned under a Rule 10b5-1 plan?

Yes. The filing states the sales followed a Rule 10b5-1 plan. A footnote explains the transactions were effected pursuant to a trading plan adopted by the reporting person on November 5, 2025, indicating they were pre‑scheduled rather than discretionary.

Who actually holds the IRMD shares involved in Roger E. Susi’s reported sales?

The sold shares are held by the Phillip Susi 2008 Dynasty Trust. The filing identifies the ownership as indirect, through this trust, and notes that Susi disclaims beneficial ownership beyond his pecuniary interest in the reported securities.

How many IRMD shares does this Form 4 show as sold versus held?

The Form 4 summarizes 7,500 IRMD shares sold in open‑market trades. It also includes holding entries for large indirect positions in other family trusts, indicating continued indirect ownership, although it does not aggregate these holdings into a single total in the summary data.

What do the weighted-average price footnotes mean in IRMD’s Form 4?

They show each sale was split across multiple trades within a price range. For several transactions, the Form 4 reports a weighted average sale price and notes that individual trade prices, within specified ranges, are available upon request to the SEC staff or shareholders.